EORTC new drug development office coordinating and monitoring programme for phase I and II trials with new anticancer agents

This publication has 10 references indexed in Scilit:

• Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug Development
  JNCI Journal of the National Cancer Institute, 1990
• Design and Analysis of Phase I Clinical Trials
  Published by JSTOR ,1989
• The main steps in the development of anticancer agents
  Radiotherapy and Oncology, 1988
• Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelines
  European Journal of Cancer and Clinical Oncology, 1987
• DO WE NEED INFORMED CONSENT?
  The Lancet, 1986
• Development of new anti-cancer drugs
  Medical Oncology and Tumor Pharmacotherapy, 1986
• EORTC guidelines for phase I trials with single agents in adults
  European Journal of Cancer and Clinical Oncology, 1985
• Informed consent
  American Journal of Clinical Oncology, 1984
• Design of Phase I and II Clinical Trials in Cancer: A Statistician's View
  Cancer Investigation, 1984
• The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
  Journal of Chronic Diseases, 1961